AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TherapeuticsMD, Inc. Director's Dealing 2016

Feb 17, 2016

35134_dirs_2016-02-16_73e59f4f-6b31-435e-8e87-a7293ad2c1db.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2015-12-31

Reporting Person: Milligan John C.K. IV (Director, President/Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-26	Common Stock	G	50000	—	Disposed	2790396	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1472419	Direct
Common Stock	1321791	Indirect

Footnotes

F1: By grantor-retained annuity trust.

F2: Includes 20,000 shares of common stock previously reported as being held directly by Mr. Milligan and 178,209 shares of common stock previously reported as being held indirectly by grantor-retained annuity trust.

F3: By John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.